Novo Nordisk Gets US Approval for Wegovy Obesity Pill 

诺和诺德获美国批准推出Wegovy肥胖药片

Bloomberg Intelligence

2025-12-24

28 分钟
PDF

单集简介 ...

Watch Scarlet and Paul LIVE every day on YouTube: http://bit.ly/3vTiACF. Bloomberg Intelligence hosted by Paul Sweeney and Scarlet Fu- John Tozzi, Bloomberg Health Care Reporter, discusses Novo Nordisk winning approval to sell a pill version of its obesity shot Wegovy in the US, to help people lose weight or maintain previous weight loss over the long term. - Reshmi Basu, Bloomberg News Credit Reporter, discusses Saks Global Enterprises, facing limited options ahead of a more than $100 million debt payment due at the end of this month, considering Chapter 11 bankruptcy.-George Ferguson, Bloomberg Intelligence Senior Aerospace, Defense, & Airlines Analyst, talks about his outlook for North Americans airlines in 2026. - Nathan Dean, Bloomberg Intelligence Senior Policy Analyst, breaks down the 2025 "Winners & Losers" See omnystudio.com/listener for privacy information.
更多

单集文稿 ...

  • What is actual investing?

  • We believe that it's a real-world task to deliver thoughtful capital deployment.

  • It's not about speculating over the short term.

  • It's about understanding the long-term opportunities for companies through technological progress or new business models.

  • So we seek out those exploring big new ideas that will change the world.

  • Then we back them to give those ideas time to flourish.

  • Hello and welcome.

  • This is The Michelle Hussein Show.

  • I'm Michelle Hussein.

  • I speak with people like Elon Musk.

  • I think I've done enough.

  • And Shonda Rhimes.

  • That's so cute.

  • This will be a place where every weekend you can count on one essential conversation to help make sense of the world.

  • So please join me.

  • Listen and subscribe to The Michelle Hussein Show from Bloomberg Weekend wherever you get your podcasts.

  • You certainly ask interesting questions.

  • Bloomberg Audio Studios.

  • Podcasts.

  • Radio.